Levocetirizine

Cetirizine Hydrochloride Tablets (5mg, 10mg) and Syrup (5mg/5ml) is a second-generation piperazine H1-antihistamine and active carboxylated metabolite of hydroxyzine on the WHO Model List of Essential Medicines. It selectively antagonizes peripheral H1 receptors, blocking histamine-induced wheal, flare, capillary permeability, and sensory nerve activation, while also inhibiting late-phase cutaneous and bronchial eosinophil recruitment. Indicated for relief of symptoms associated with seasonal and perennial allergic rhinitis, allergic conjunctivitis, and chronic idiopathic urticaria.

Montelukast Sodium (4mg/10mg) and Levocetirizine Dihydrochloride (2.5mg/5mg Tablets, Syrup, with or without Ambroxol SR 75mg) is a premier dual-action antiallergic and anti-inflammatory combination on the WHO Model List framework. Montelukast is a selective cysteinyl leukotriene receptor-1 (CysLT1) antagonist that blocks the bronchoconstricting, mucus-secreting, and eosinophil-recruiting actions of LTD4. Levocetirizine is an active R-enantiomer second-generation H1-antihistamine that blocks histamine-mediated itching, sneezing, and vascular permeability. Together, they simultaneously block both early-phase (histamine) and late-phase (leukotriene) allergic inflammatory cascades. Indicated for seasonal and perennial allergic rhinitis, allergic rhinitis with co-existing asthma, and chronic urticaria.

Cetirizine Hydrochloride Tablets (5mg, 10mg) and Syrup (5mg/5ml) is a second-generation piperazine H1-antihistamine and active carboxylated metabolite of hydroxyzine on the WHO Model List of Essential Medicines. It selectively antagonizes peripheral H1 receptors, blocking histamine-induced wheal, flare, capillary permeability, and sensory nerve activation, while also inhibiting late-phase cutaneous and bronchial eosinophil recruitment. Indicated for relief of symptoms associated with seasonal and perennial allergic rhinitis, allergic conjunctivitis, and chronic idiopathic urticaria.

Montelukast Sodium (4mg/10mg) and Levocetirizine Dihydrochloride (2.5mg/5mg Tablets, Syrup, with or without Ambroxol SR 75mg) is a premier dual-action antiallergic and anti-inflammatory combination on the WHO Model List framework. Montelukast is a selective cysteinyl leukotriene receptor-1 (CysLT1) antagonist that blocks the bronchoconstricting, mucus-secreting, and eosinophil-recruiting actions of LTD4. Levocetirizine is an active R-enantiomer second-generation H1-antihistamine that blocks histamine-mediated itching, sneezing, and vascular permeability. Together, they simultaneously block both early-phase (histamine) and late-phase (leukotriene) allergic inflammatory cascades. Indicated for seasonal and perennial allergic rhinitis, allergic rhinitis with co-existing asthma, and chronic urticaria.

Montelukast Sodium (4mg/10mg) and Levocetirizine Dihydrochloride (2.5mg/5mg Tablets, Syrup, with or without Ambroxol SR 75mg) is a premier dual-action antiallergic and anti-inflammatory combination on the WHO Model List framework. Montelukast is a selective cysteinyl leukotriene receptor-1 (CysLT1) antagonist that blocks the bronchoconstricting, mucus-secreting, and eosinophil-recruiting actions of LTD4. Levocetirizine is an active R-enantiomer second-generation H1-antihistamine that blocks histamine-mediated itching, sneezing, and vascular permeability. Together, they simultaneously block both early-phase (histamine) and late-phase (leukotriene) allergic inflammatory cascades. Indicated for seasonal and perennial allergic rhinitis, allergic rhinitis with co-existing asthma, and chronic urticaria.

Cetirizine Hydrochloride Tablets (5mg, 10mg) and Syrup (5mg/5ml) is a second-generation piperazine H1-antihistamine and active carboxylated metabolite of hydroxyzine on the WHO Model List of Essential Medicines. It selectively antagonizes peripheral H1 receptors, blocking histamine-induced wheal, flare, capillary permeability, and sensory nerve activation, while also inhibiting late-phase cutaneous and bronchial eosinophil recruitment. Indicated for relief of symptoms associated with seasonal and perennial allergic rhinitis, allergic conjunctivitis, and chronic idiopathic urticaria.

Cetirizine Hydrochloride Tablets (5mg, 10mg) and Syrup (5mg/5ml) is a second-generation piperazine H1-antihistamine and active carboxylated metabolite of hydroxyzine on the WHO Model List of Essential Medicines. It selectively antagonizes peripheral H1 receptors, blocking histamine-induced wheal, flare, capillary permeability, and sensory nerve activation, while also inhibiting late-phase cutaneous and bronchial eosinophil recruitment. Indicated for relief of symptoms associated with seasonal and perennial allergic rhinitis, allergic conjunctivitis, and chronic idiopathic urticaria.